Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007· article· en· Clinical Cancer Research· Biochemistry, Genetics and Molecular Biology
affabout
5 106
citations
Travaux
Tous les travaux de la base. Chaque rangée indique les voies par lesquelles le travail a été admis, car une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée.
Voie
Domaine
Type
Langue
Période
à
Consensus du tri
Ordre
Indicateurs
Données de dépistage
Les étiquettes directes sont rares et non validées. Une absence reste inconnue.
1 filtre actif
2 781 travauxpage 1 sur 112
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
2010· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
aboutno aff
4 267
citations
Triple-Negative Breast Cancer
2010· review· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
4 170
citations
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006· article· en· JAMA· Biochemistry, Genetics and Molecular Biology
aff
3 834
citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
2013· article· en· Annals of Oncology· Biochemistry, Genetics and Molecular Biology
affsans résumé
3 715
citations
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
2018· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
afffund
2 369
citations
Metastatic Behavior of Breast Cancer Subtypes
2010· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
aff
2 284
citations
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009· article· en· JNCI Journal of the National Cancer Institute· Biochemistry, Genetics and Molecular Biology
aff
2 220
citations
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
affsans résumé
1 919
citations
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
1 867
citations
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
2017· review· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
1 810
citations
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
2020· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
aff
1 497
citations
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
2015· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
afffund
1 439
citations
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
2009· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
affsans résumé
1 405
citations
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
fundno aff
1 386
citations
Regional Nodal Irradiation in Early-Stage Breast Cancer
2015· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
afffundabout
1 296
citations
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
2017· article· en· Annals of Oncology· Biochemistry, Genetics and Molecular Biology
affsans résumé
1 255
citations
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
2010· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
aff
1 242
citations
Ki67 in breast cancer: prognostic and predictive potential
2010· review· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
affsans résumé
1 226
citations
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
2008· article· en· Clinical Cancer Research· Biochemistry, Genetics and Molecular Biology
afffund
1 188
citations
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
2010· review· en· PLoS Medicine· Biochemistry, Genetics and Molecular Biology
afffund
1 150
citations
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
2005· article· en· JNCI Journal of the National Cancer Institute· Biochemistry, Genetics and Molecular Biology
aff
1 120
citations
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
2007· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
affsans résumé
1 078
citations
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
2020· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
affsans résumé
1 060
citations
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
2010· review· en· Archives of Pathology & Laboratory Medicine· Biochemistry, Genetics and Molecular Biology
aboutno aff
1 048
citations